[BPH pharmacotherapy (miscellaneous)].
Okada
Hiroshi
H
Division of Urology, Department of Organs Therapeutics, Faculty of Medicine, Kobe University Graduate School of Medicine.
D000409:Alanine / Q000627:therapeutic use*; D004338:Drug Combinations; D004979:Ethamsylate / Q000627:therapeutic use*; D005971:Glutamates / Q000627:therapeutic use*; D005998:Glycine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010936:Plant Extracts / Q000627:therapeutic use*; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D012434:Secale; D016896:Treatment Outcome
D004338:Drug Combinations; D005971:Glutamates; D010936:Plant Extracts; D004979:Ethamsylate; C010152:eviprostat; C010070:cernilton; C003048:Paraprost; D000409:Alanine; D005998:Glycine